HUM vs INVX · P/E 39, rev $117.76B vs P/E 8.0, rev $660.8M
Humana Inc (HUM) versus Innovex International, Inc (INVX) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Innovex International, Inc (INVX) is a oil & gas equipment & services company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported INVX revenue for 2024-12-31 was $660.8M. Net income was $140.3M. Revenue was up 55.8% from 2023-12-31 to 2024-12-31. INVX currently screens at market cap $1.10B and trailing P/E 8.0.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. INVX currently screens at market cap $1.10B and trailing P/E 8.0.
Not investment advice. Open the HUM and INVX stock pages for the full models.
Not investment advice.